Skip to main content

Advertisement

Log in

Type 2 Diabetes Mellitus, the Metabolic Syndrome, and Its Components in Adult Survivors of Acute Lymphoblastic Leukemia and Hematopoietic Stem Cell Transplantations

  • Pediatric Type 2 and Monogenic Diabetes (PS Zeitler and O Pinhas-Hamiel, Section Editors)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

A growing number of pediatric acute lymphoblastic leukemia (ALL) and hematopoietic stem cell transplantation (HSCT) survivors reach adulthood and face long-term health-related problems. We review risk factors and the prevalence of the metabolic syndrome (MetS), a cluster of obesity-related comorbidities, including abdominal obesity, atherogenic dyslipidemia, elevated blood pressure, impaired glucose metabolism, and type 2 diabetes in ALL and HSCT survivors.

Recent Findings

Components of the MetS are already detected during the first year of ALL maintenance therapy and significantly worsen over time. The prevalence of MetS increases at a faster rate in this setting than in the general population. Factors found to be of the greatest potential risk to the development of the MetS are central obesity, increased BMI, irradiation therapy, older age, poor diet, and low level of physical activity.

Summary

The early onset of MetS and its components among ALL and HSCT survivors calls for early and continuous screening to identify those at risk and to implement preventive measures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Abarca-Gómez L, Abdeen ZA, Hamid ZA, Abu-Rmeileh NM, Acosta-Cazares B, Acuin C, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–42. https://doi.org/10.1016/S0140-6736(17)32129-3.

    Article  Google Scholar 

  2. Garrido-Miguel M, Cavero-Redondo I, Álvarez-Bueno C, Rodriguez-Artalejo F, Moreno Aznar L, Ruiz JR et al. Prevalence and trends of thinness, overweight and obesity among children and adolescents aged 3–18 years across Europe: a protocol for a systematic review and meta-analysis. BMJ Open. 2017;7(12). doi:https://doi.org/10.1136/bmjopen-2017-018241.

  3. Smith SC Jr, Clark LT, Cooper RS, Daniels SR, Kumanyika SK, Ofili E, et al. Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group. Circulation. 2005;111(10):e134–9. https://doi.org/10.1161/01.CIR.0000157743.54710.04.

    Article  PubMed  Google Scholar 

  4. Pinhas-Hamiel O. Metabolic syndrome in children and adolescents worldwide. In: Nadeau K, Zeitler P, editors. Insulin resistance: childhood precursors and adult disease. Contemporary Endocrinology. The Humana Press Inc; 2008. p. 45–64. Chapter 3.

  5. Alberti KG, Zimmet P, Shaw J, Group IDFETFC. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366(9491):1059–62. https://doi.org/10.1016/S0140-6736(05)67402-8.

    Article  PubMed  Google Scholar 

  6. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med: J Br Diabetic Assoc. 1998;15(7):539–53. https://doi.org/10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.

    Article  CAS  Google Scholar 

  7. Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285(19):2486–97.

    Article  Google Scholar 

  8. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med. 2003;157(8):821–7. https://doi.org/10.1001/archpedi.157.8.821.

    Article  PubMed  Google Scholar 

  9. • Nottage KA, Ness KK, Li C, Srivastava D, Robison LL, Hudson MM. Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia—from the St. Jude Lifetime Cohort. Br J Haematol. 2014;165(3):364–74. https://doi.org/10.1111/bjh.12754. This is the largest study providing data on 784 adult survivors with comparison to race matched control from the USA.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. • Saultier P, Auquier P, Bertrand Y, Vercasson C, Oudin C, Contet A, et al. Metabolic syndrome in long-term survivors of childhood acute leukemia treated without hematopoietic stem cell transplantation: an L.E.A. study. Haematologica. 2016;101(12):1603–10. https://doi.org/10.3324/haematol.2016.148908. This is a large study providing data on 650 adult survivors from Europe.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. • Oudin C, Auquier P, Bertrand Y, Contet A, Kanold J, Sirvent N, et al. Metabolic syndrome in adults who received hematopoietic stem cell transplantation for acute childhood leukemia: an LEA study. Bone Marrow Transplant. 2015;50(11):1438–44. https://doi.org/10.1038/bmt.2015.167. This study emphasize the impact of hematopoietic stem cell transplantation on the development of the MetS in a large population of survivors.

    Article  PubMed  CAS  Google Scholar 

  12. Trimis G, Moschovi M, Papassotiriou I, Chrousos G, Tzortzatou-Stathopoulou F. Early indicators of dysmetabolic syndrome in young survivors of acute lymphoblastic leukemia in childhood as a target for preventing disease. J Pediatr Hematol Oncol. 2007;29(5):309–14. https://doi.org/10.1097/MPH.0b013e318059c249.

    Article  PubMed  Google Scholar 

  13. Mohapatra S, Bansal D, Bhalla AK, Verma Attri S, Sachdeva N, Trehan A, et al. Is there an increased risk of metabolic syndrome among childhood acute lymphoblastic leukemia survivors? A developing country experience. Pediatr Hematol Oncol. 2016;33(2):136–49. https://doi.org/10.3109/08880018.2016.1152335.

    Article  PubMed  CAS  Google Scholar 

  14. Aldhafiri F, Al-Nasser A, Al-Sugair A, Al-Mutairi H, Young D, Reilly JJ. Obesity and metabolic syndrome in adolescent survivors of standard risk childhood acute lymphoblastic leukemia in Saudi Arabia. Pediatr Blood Cancer. 2012;59(1):133–7. https://doi.org/10.1002/pbc.24012.

    Article  PubMed  Google Scholar 

  15. Barbosa-Cortés L, López-Alarcón M, Mejía-Aranguré JM, Klünder-Klünder M, del Carmen Rodríguez-Zepeda M, Rivera-Márquez H, et al. Adipokines, insulin resistance, and adiposity as a predictors of metabolic syndrome in child survivors of lymphoma and acute lymphoblastic leukemia of a developing country. BMC Cancer. 2017;17(1):125. https://doi.org/10.1186/s12885-017-3097-8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Chow EJ, Simmons JH, Roth CL, Baker KS, Hoffmeister PA, Sanders JE, et al. Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2010;16(12):1674–81. https://doi.org/10.1016/j.bbmt.2010.05.016.

    Article  Google Scholar 

  17. Zareifar S, Haghpanah S, Shorafa E, Shakibazad N, Karamizadeh Z. Evaluation of metabolic syndrome and related factors in children affected by acute lymphoblastic leukemia. Indian J Med Paediatr Oncol: Off J Indian Soc Med Paediatr Oncol. 2017;38(2):97–102. https://doi.org/10.4103/ijmpo.ijmpo_69_16.

    Article  Google Scholar 

  18. Karakurt H, Sarper N, Kılıç SÇ, Gelen SA, Zengin E. Screening survivors of childhood acute lymphoblastic leukemia for obesity, metabolic syndrome, and insulin resistance. Pediatr Hematol Oncol. 2012;29(6):551–61. https://doi.org/10.3109/08880018.2012.708892.

    Article  PubMed  CAS  Google Scholar 

  19. Engin A. The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol. 2017;960:1–17. https://doi.org/10.1007/978-3-319-48382-5_1.

    Article  PubMed  CAS  Google Scholar 

  20. Wei C, Thyagiarajan M, Hunt L, Cox R, Bradley K, Elson R, et al. Reduced beta-cell reserve and pancreatic volume in survivors of childhood acute lymphoblastic leukaemia treated with bone marrow transplantation and total body irradiation. Clin Endocrinol. 2015;82(1):59–67. https://doi.org/10.1111/cen.12575.

    Article  CAS  Google Scholar 

  21. Malhotra J, Tonorezos ES, Rozenberg M, Vega GL, Sklar CA, Chou J, et al. Atherogenic low density lipoprotein phenotype in long-term survivors of childhood acute lymphoblastic leukemia. J Lipid Res. 2012;53(12):2747–54. https://doi.org/10.1194/jlr.P029785.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Wei C, Hunt L, Cox R, Bradley K, Elson R, Shield J, et al. Identifying cardiovascular risk in survivors of childhood leukaemia treated with haematopoietic stem cell transplantation and total body irradiation. Horm Res Paediatr. 2017;87(2):116–22.

    Article  PubMed  CAS  Google Scholar 

  23. Chow EJ, Pihoker C, Hunt K, Wilkinson K, Friedman DL. Obesity and hypertension among children after treatment for acute lymphoblastic leukemia. Cancer. 2007;110(10):2313–20. https://doi.org/10.1002/cncr.23050.

    Article  PubMed  Google Scholar 

  24. Esbenshade AJ, Simmons JH, Koyama T, Koehler E, Whitlock JA, Friedman DL. Body mass index and blood pressure changes over the course of treatment of pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2011;56(3):372–8. https://doi.org/10.1002/pbc.22782.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Morel S, Leahy J, Fournier M, Lamarche B, Garofalo C, Grimard G, et al. Lipid and lipoprotein abnormalities in acute lymphoblastic leukemia survivors. J Lipid Res. 2017;58(5):982–93. https://doi.org/10.1194/jlr.M072207.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Esbenshade AJ, Simmons JH, Koyama T, Lindell RB, Friedman DL. Obesity and insulin resistance in pediatric acute lymphoblastic leukemia worsens during maintenance therapy. Pediatr Blood Cancer. 2013;60(8):1287–91. https://doi.org/10.1002/pbc.24489.

    Article  PubMed  CAS  Google Scholar 

  27. Bizzarri C, Pinto RM, Ciccone S, Brescia LP, Locatelli F, Cappa M. Early and progressive insulin resistance in young, non-obese cancer survivors treated with hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2015;62(9):1650–5. https://doi.org/10.1002/pbc.25603.

    Article  PubMed  CAS  Google Scholar 

  28. Taskinen M, Saarinen-Pihkala UM, Hovi L, Lipsanen-Nyman M. Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet. 2000;356(9234):993–7. https://doi.org/10.1016/S0140-6736(00)02717-3.

    Article  PubMed  CAS  Google Scholar 

  29. Gurney JG, Ness KK, Sibley SD, O'Leary M, Dengel DR, Lee JM, et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer. 2006;107(6):1303–12. https://doi.org/10.1002/cncr.22120.

    Article  PubMed  CAS  Google Scholar 

  30. Tahrani AA, Cramp C, Moulik P. The development of non-insulin-dependent diabetes after total body irradiation and bone marrow transplantation in adolescence: a case report and literature review. Pediatr Diabetes. 2006;7(3):173–5. https://doi.org/10.1111/j.1399-543X.2006.00160.x.

    Article  PubMed  Google Scholar 

  31. Hirayama M, Azuma E, Kumamoto T, Qi J, Kobayashi M, Komada Y, et al. Late-onset unilateral renal dysfunction combined with non-insulin-dependent diabetes mellitus and bronchial asthma following allogeneic bone marrow transplantation for acute lymphoblastic leukemia in a child. Bone Marrow Transplant. 1998;22:923–6. https://doi.org/10.1038/sj.bmt.1701462.

    Article  PubMed  CAS  Google Scholar 

  32. Neville KA, Cohn RJ, Steinbeck KS, Johnston K, Walker JL. Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors. J Clin Endocrinol Metab. 2006;91(11):4401–7. https://doi.org/10.1210/jc.2006-0128.

    Article  PubMed  CAS  Google Scholar 

  33. Hoffmeister PA, Storer BE, Sanders JE. Diabetes mellitus in long-term survivors of pediatric hematopoietic cell transplantation. J Pediatr Hematol Oncol. 2004;26(2):81–90.

    Article  PubMed  Google Scholar 

  34. Bielorai B, Weintraub Y, Hutt D, Hemi R, Kanety H, Modan-Moses D et al. The metabolic syndrome and its components in pediatric survivors of allogeneic hematopoietic stem cell transplantation. Clin Transpl. 2017;31(3). doi:https://doi.org/10.1111/ctr.12903.

  35. Oudin C, Simeoni MC, Sirvent N, Contet A, Begu-Le Coroller A, Bordigoni P, et al. Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood. 2011;117(17):4442–8. https://doi.org/10.1182/blood-2010-09-304899.

    Article  PubMed  CAS  Google Scholar 

  36. Bajwa R, Skeens M, Garee A, Miao Y, Soni S, Pietryga D, et al. Metabolic syndrome and endocrine dysfunctions after HSCT in children. Pediatr Transplant. 2012;16(8):872–8. https://doi.org/10.1111/petr.12002.

    Article  PubMed  Google Scholar 

  37. Iughetti L, Bruzzi P, Predieri B, Paolucci P. Obesity in patients with acute lymphoblastic leukemia in childhood. Ital J Pediatr. 2012;38:4. https://doi.org/10.1186/1824-7288-38-4.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Kyle UG, Chalandon Y, Miralbell R, Karsegard VL, Hans D, Trombetti A, et al. Longitudinal follow-up of body composition in hematopoietic stem cell transplant patients. Bone Marrow Transplant. 2005;35(12):1171–7. https://doi.org/10.1038/sj.bmt.1704996.

    Article  PubMed  CAS  Google Scholar 

  39. Blijdorp K, van den Heuvel-Eibrink MM, Pieters R, Boot AM, Delhanty PJ, van der Lely AJ, et al. Obesity is underestimated using body mass index and waist-hip ratio in long-term adult survivors of childhood cancer. PLoS One. 2012;7(8):e43269. https://doi.org/10.1371/journal.pone.0043269.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Jarfelt M, Lannering B, Bosaeus I, Johannsson G, Bjarnason R. Body composition in young adult survivors of childhood acute lymphoblastic leukaemia. Eur J Endocrinol. 2005;153(1):81–9. https://doi.org/10.1530/eje.1.01931.

    Article  PubMed  CAS  Google Scholar 

  41. Paris C, Yates L, Lama P, Zepeda AJ, Gutierrez D, Palma J. Evaluation of metabolic syndrome after hematopoietic stem cell transplantation in children and adolescents. Pediatr Blood Cancer. 2012;59(2):306–10. https://doi.org/10.1002/pbc.24104.

    Article  PubMed  Google Scholar 

  42. Taskinen M, Lipsanen-Nyman M, Tiitinen A, Hovi L, Saarinen-Pihkala UM. Insufficient growth hormone secretion is associated with metabolic syndrome after allogeneic stem cell transplantation in childhood. J Pediatr Hematol Oncol. 2007;29(8):529–34. https://doi.org/10.1097/MPH.0b013e3180f61b67.

    Article  PubMed  CAS  Google Scholar 

  43. Majhail NS, Rizzo JD. Surviving the cure: long term followup of hematopoietic cell transplant recipients. Bone Marrow Transplant. 2013;48(9):1145–51. https://doi.org/10.1038/bmt.2012.258.

    Article  PubMed  CAS  Google Scholar 

  44. Majhail NS, Flowers ME, Ness KK, Jagasia M, Carpenter PA, Arora M, et al. High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2009;43(1):49–54. https://doi.org/10.1038/bmt.2008.263.

    Article  PubMed  CAS  Google Scholar 

  45. Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006;113(15):1888–904. https://doi.org/10.1161/CIRCULATIONAHA.105.563213.

    Article  PubMed  Google Scholar 

  46. Janiszewski PM, Oeffinger KC, Church TS, Dunn AL, Eshelman DA, Victor RG, et al. Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia. J Clin Endocrinol Metab. 2007;92(10):3816–21. https://doi.org/10.1210/jc.2006-2178.

    Article  PubMed  CAS  Google Scholar 

  47. Ness KK, Baker KS, Dengel DR, Youngren N, Sibley S, Mertens AC, et al. Body composition, muscle strength deficits and mobility limitations in adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2007;49(7):975–81. https://doi.org/10.1002/pbc.21091.

    Article  PubMed  Google Scholar 

  48. Warris LT, van den Akker EL, Bierings MB, van den Bos C, Zwaan CM, Sassen SD, et al. Acute activation of metabolic syndrome components in pediatric acute lymphoblastic leukemia patients treated with dexamethasone. PLoS One. 2016;11(6):e0158225. https://doi.org/10.1371/journal.pone.0158225.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, et al. Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT. Bone Marrow Transplant. 2017;52(2):173–82. https://doi.org/10.1038/bmt.2016.203.

    Article  PubMed  CAS  Google Scholar 

  50. Tonorezos ES, Robien K, Eshelman-Kent D, Moskowitz CS, Church TS, Ross R, et al. Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia. Cancer Causes Control: CCC. 2013;24(2):313–21. https://doi.org/10.1007/s10552-012-0116-6.

    Article  PubMed  Google Scholar 

  51. Slater ME, Ross JA, Kelly AS, Dengel DR, Hodges JS, Sinaiko AR, et al. Physical activity and cardiovascular risk factors in childhood cancer survivors. Pediatr Blood Cancer. 2015;62(2):305–10. https://doi.org/10.1002/pbc.25276.

    Article  PubMed  Google Scholar 

  52. Chow EJ, Wong K, Lee SJ, Cushing-Haugen KL, Flowers ME, Friedman DL, et al. Late cardiovascular complications after hematopoietic cell transplantation. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2014;20(6):794–800. https://doi.org/10.1016/j.bbmt.2014.02.012.

    Article  Google Scholar 

  53. Viner Smith E, Tierney AC, Klarica D, Walker P, Avery S. Impact of a lifestyle modification program on the metabolic syndrome and associated risk factors in long-term survivors of stem cell transplantation. Bone Marrow Transplant. 2015;51:722–4. https://doi.org/10.1038/bmt.2015.312.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors are grateful to Mrs. Cindy Cohen for editorial assistance in preparing the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Orit Pinhas-Hamiel.

Ethics declarations

Conflict of Interest

Bella Bielorai and Orit Pinhas-Hamiel declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Pediatric Type 2 and Monogenic Diabetes

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bielorai, B., Pinhas-Hamiel, O. Type 2 Diabetes Mellitus, the Metabolic Syndrome, and Its Components in Adult Survivors of Acute Lymphoblastic Leukemia and Hematopoietic Stem Cell Transplantations. Curr Diab Rep 18, 32 (2018). https://doi.org/10.1007/s11892-018-0998-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11892-018-0998-0

Keywords

Navigation